ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,419Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 123

$492K Total Retail Price of All Prescriptions

Rank: 12 out of 123

601 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 7,567 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
CLOPIDOGREL 670 435 1 7
CARVEDILOL 590 470 2 1
PRAVASTATIN SODIUM 581 437 3 8
FUROSEMIDE 449 320 4 4
PLAVIX 448 317 5 13
SIMVASTATIN 374 296 6 6
METOPROLOL TARTRATE 350 201 7 9
AMLODIPINE BESYLATE 346 254 8 5
NITROSTAT 322 237 9 23
WARFARIN SODIUM 311 233 10 12
POTASSIUM CHLORIDE 310 238 11 14
ISOSORBIDE MONONITRATE ER 253 181 12 11
TORSEMIDE 249 195 13 69
LISINOPRIL 209 147 14 2
DIOVAN 203 156 15 25
ATORVASTATIN CALCIUM 184 106 16 10
METOPROLOL SUCCINATE 181 139 17 3
PROPAFENONE HCL 180 163 18 34
CLONIDINE HCL 166 125 19 40
DILTIAZEM HCL 153 125 20 102
KLOR-CON M20 132 76 21 36
LEVOTHYROXINE SODIUM 130 107 22 30
OMEPRAZOLE 120 80 23 22
NITROGLYCERIN PATCH 118 75 24 54
HYDROCHLOROTHIAZIDE 118 81 24 19
HYDRALAZINE HCL 115 100 26 28
DIGOXIN 113 83 27 16
SOTALOL 111 98 28 24
ATENOLOL 109 72 29 20
CRESTOR 104 59 30 15
ENALAPRIL MALEATE 98 67 31 39
RAMIPRIL 98 70 31 29
PANTOPRAZOLE SODIUM 96 79 33 37
KLOR-CON 10 90 62 34 78
DILTIAZEM 24HR CD 81 71 35 43
MIDODRINE HCL 80 54 36 88
FOSINOPRIL SODIUM 79 52 37 98
LOSARTAN POTASSIUM 73 66 38 21
DILTIAZEM ER 67 57 39 62
LOVASTATIN 66 65 40 49
ZETIA 64 29 41 33
BENAZEPRIL HCL 62 39 42 53
TRICOR 62 45 42 61
NEXIUM 60 52 44 63
DILTIAZEM 24HR ER 56 34 45 75
TRILIPIX 53 20 46 59
RANITIDINE HCL 53 18 46 93
ALLOPURINOL 52 39 48 76
ISOSORBIDE DINITRATE 50 43 49 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 7, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.